Table 2. IC₅₀ (μM) Values of Synthesized Complexes Calculated from Percent (%) Viability Values in Different Cell Lines.

Comp	HepG2	Caco-2	HT-29	MCF-7	A549	HEK293T
Ru1S	26.51 ± 10.43	18.61 ± 4.96	64.0 ± 22.62	17.18 ± 3.84	131.48 ± 22.83	169.48 ± 97.97
Ru2S	78.84 ± 42.81	10.98 ± 2.47	19.41 ± 5.58	17.96 ± 5.55	94.15 ± 14.76	144.43 ± 158.6
Ru3S	7.13 ± 2.12	9.57 ± 2.33	6.93 ± 1.76	12.09 ± 3.36	25.24 ± 2.87	83.79 ± 58.05
Ru4S	23.76 ± 4.23	2.47 ± 0.42	6.24 ± 1.36	5.35 ± 0.78	29.90 ± 4.48	33.15 ± 9.17
Ru5S	27.36 ± 5.62	11.44 ± 3.76	21.88 ± 7.19	9.47 ± 1.96	34.72 ± 4.78	87.34 ± 35.95
Ru6S	54.79 ± 28.65	12.42 ± 2.75	41.77 ± 11.88	19.33 ± 4.09	65.03 ± 12.40	66.15 ± 18.46
Ru7S	30.01 ± 6.51	17.01 ± 4.25	14.60 ± 3.46	10.11 ± 2.65	172.97 ± 57.41	764.61 ± 188
Ru8S	25.65 ± 4.43	20.45 ± 4.80	33.56 ± 10.17	33.07 ± 12.50	92.36 ± 19.80	16.55 ± 18.32
Srf	5.20 ± 1.66	13.80 ± 3.89	7.89 ± 2.53	10.55 ± 2.60	7.48 ± 0.86	0.15 ± 0.16